Proficio Capital Partners LLC Eagle Pharmaceuticals, Inc. Transaction History

Proficio Capital Partners LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$53.25 - $59.98 $7,934 - $8,937	-149 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$46.61 - $58.45 $1,351 - $1,695	-29 Reduced 16.29%	149 $8,000
Q1 2019 May 13, 2019	BUY	$38.66 - $51.82 $6,881 - $9,223	178 New	178 $9,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.